Cat. No. 4014
Alternative Name: Alendronate sodium
Chemical Name: P,P'-(4-Amino-1-hydroxybutylidene)bi
Biological ActivityOsteoclast-mediated bone resorption inhibitor. Binds and blocks farnesyl diphosphate synthase (FPPS) in the HMG-CoA pathway (IC50 = 460 nM for recombinant human FPPS); causes macrophage apoptosis. Inhibits prenylation and sterol biosynthesis in purified osteoclasts.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Fournier et al (2008) Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vitro. Cancer Res. 68 8945. PMID: 18974139.
Bergstrom et al (2000) Alendronate is a specific, nanomolar inhibitor of fanesyl diphosphate synthase. Arch.Biochem.Biophys. 373 231. PMID: 10620343.
Fisher et al (1999) Alendronate mechanism of action; geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc.Natl.Acad.Sci. 96 133.
If you know of a relevant reference for MK 217 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses MK 217 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: MK 217, supplier, MK217, osteoclasts, mediated, bone, resorption, osteoporosis, inhibits, farnesyl, diphosphate, synthase, inhibitors, Tocris Bioscience, Other Synthase/Synthetase Inhibitor products